Cobram Estate Olives Limited (ASX:CBO)
Australia · Delayed Price · Currency is AUD | Market Cap | 1.78B +136.2% |
| Revenue (ttm) | 233.59M -2.5% |
| Net Income | 42.16M +98.0% |
| EPS | 0.09 +89.6% |
| Shares Out | 478.79M |
| PE Ratio | 40.09 |
| Forward PE | 35.63 |
| Dividend | 0.05 (1.21%) |
| Ex-Dividend Date | Nov 6, 2025 |
| Volume | 709,344 |
| Average Volume | 975,813 |
| Open | 3.720 |
| Previous Close | 3.720 |
| Day's Range | 3.640 - 3.740 |
| 52-Week Range | 1.815 - 4.110 |
| Beta | 0.33 |
| RSI | 65.19 |
| Earnings Date | May 21, 2026 |
About Cobram Estate Olives
Cobram Estate Olives Limited engages in production and marketing of olive oil in Australia, the United States, and internationally. Its olive farming assets include various olive trees of freehold farmland in Victoria; and long-term leased and freehold properties in California. The company is also involved in olive farming; and owns olive tree nursery, olive mills, olive oil bottling and storage facilities, and olives laboratory. In addition, it sells online olive leaf teas and refined olive oil. It sells its products under the Cobram Estate, R... [Read more]
Financial Performance
In fiscal year 2025, Cobram Estate Olives's revenue was 242.36 million, an increase of 6.14% compared to the previous year's 228.34 million. Earnings were 49.63 million, an increase of 167.82%.
Financial StatementsNews
Solum Partners Announces Sale of California Olive Ranch to Cobram Estate Olives
BOSTON--(BUSINESS WIRE)--Solum Partners, a specialist investment firm focused on vertically integrated food and natural capital businesses, today announced the sale of its portfolio company, Californi...
Cobram Estate Olives Earnings Call Transcript: H1 2026
Underlying EBITDA was AUD 9.5 million, ahead of guidance but down year-over-year, with a net loss after tax of AUD 11.9 million due to transaction costs. The COR acquisition will expand U.S. operations and is expected to deliver significant synergies and growth.
Cobram Estate Olives Transcript: AGM 2025
Record financial results were achieved, with strong growth in both Australia and the U.S., and a major capital raise is accelerating U.S. expansion. The board emphasized sustainability, risk management, and long-term value creation, while all resolutions and director re-elections were supported.
Cobram Estate Olives Earnings Call Transcript: H2 2025
Record profit and cash flow were achieved, driven by strong branded sales growth in both Australia and the U.S.A. Major CapEx in Australia is complete, with future investment focused on U.S. expansion. Water costs and global supply constraints remain key risks.
Cobram Estate Olives Earnings Call Transcript: H1 2025
Sales rose 13.5% to AUD 123.5 million, with EBITDA up 75% and strong growth in both Australia and the U.S. CapEx focused on U.S. expansion, and a larger Australian crop is expected to boost second-half results. Demand remains robust despite global price shifts.
Cobram Estate Olives Transcript: AGM 2024
The AGM highlighted strong financial results, major growth in both Australia and the U.S.A., and a focus on sustainability and risk management. Shareholders approved all resolutions, including director elections and a fully franked dividend, while management outlined ongoing strategic investments and operational resilience.
Cobram Estate Olives Earnings Call Transcript: H2 2024
Sales grew 34.6% year-over-year, with EBITDA up 63.4% and record operating cash flow. Strong growth in both Australia and the USA, with further expansion and higher EBITDA expected in FY 2025. Market share gains, robust demand, and strategic investments position the business for continued growth.